ArticleMedicina (Kaunas, Lithuania)2022
Diagnosing Coronary Artery Disease on the Basis of Hard Ensemble Voting Optimization.
Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Coronary artery disease prediction using Bayesian-optimized support vector machine with feature selection.Frontiers in network physiology · 2025Article
- Use machine learning models to identify and assess risk factors for coronary artery disease.PloS one · 2024Article
- Predicting stroke and mortality in mitral stenosis with atrial flutter: A machine learning approach.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2023Article
- Multi-objective deep learning framework for COVID-19 dataset problems.Journal of King Saud University. Science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Recently, many studies have focused on the early diagnosis of coronary artery disease (CAD), which is one of the leading causes of cardiac-associated death worldwide. The effectiveness of the most important features influencing disease diagnosis determines the performance of machine learning systems that can allow for timely and accurate treatment. We performed a Hybrid ML framework based on hard ensemble voting optimization (HEVO) to classify patients with CAD using the Z-Alizadeh Sani dataset. All categorical features were converted to numerical forms, the synthetic minority oversampling technique (SMOTE) was employed to overcome imbalanced distribution between two classes in the dataset, and then, recursive feature elimination (RFE) with random forest (RF) was used to obtain the best subset of features. Materials and Methods: After solving the biased distribution in the CAD data set using the SMOTE method and finding the high correlation features that affected the classification of CAD patients. The performance of the proposed model was evaluated using grid search optimization, and the best hyperparameters were identified for developing four applications, namely, RF, AdaBoost, gradient-boosting, and extra trees based on an HEV classifier. Results: Five fold cross-validation experiments with the HEV classifier showed excellent prediction performance results with the 10 best balanced features obtained using SMOTE and feature selection. All evaluation metrics results reached > 98% with the HEV classifier, and the gradient-boosting model was the second best classification model with accuracy = 97% and F1-score = 98%. Conclusions: When compared to modern methods, the proposed method perform well in diagnosing coronary artery disease, and therefore, the proposed method can be used by medical personnel for supplementary therapy for timely, accurate, and efficient identification of CAD cases in suspected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.